Pharmaceutics (Jun 2024)

Prospect of Gold Nanoparticles in Pancreatic Cancer

  • Tianyi Yin,
  • Jingrun Han,
  • Yuying Cui,
  • Dong Shang,
  • Hong Xiang

DOI
https://doi.org/10.3390/pharmaceutics16060806
Journal volume & issue
Vol. 16, no. 6
p. 806

Abstract

Read online

Pancreatic cancer (PC) is characterized by its notably poor prognosis and high mortality rate, underscoring the critical need for advancements in its diagnosis and therapy. Gold nanoparticles (AuNPs), with their distinctive physicochemical characteristics, demonstrate significant application potential in cancer therapy. For example, upon exposure to lasers of certain wavelengths, they facilitate localized heating, rendering them extremely effective in photothermal therapy. Additionally, their extensive surface area enables the conjugation of therapeutic agents or targeting molecules, increasing the accuracy of drug delivery systems. Moreover, AuNPs can serve as radiosensitizers, enhancing the efficacy of radiotherapy by boosting the radiation absorption in tumor cells. Here, we systematically reviewed the application and future directions of AuNPs in the diagnosis and treatment of PC. Although AuNPs have advantages in improving diagnostic and therapeutic efficacy, as well as minimizing damage to normal tissues, concerns about their potential toxicity and safety need to be comprehensively evaluated.

Keywords